Pugwash Is Alive and Well, Thank You

Frank Barnaby’s article “The Pugwash Conference Turns 30” (THE SCIENTIST, June 29, 1987, p. 11)is, on the whole, a fair assessment of the early accomplishments of Pugwash; but it does not do justice to its activities and development during the past decade. For example, Barnaby states that Pugwash “has already begun to fade away, leaving its goal of complete nuclear disarmament still totally unfulfilled.” That goal remains the centerpiece of Pugwash’s hope fo

Written byMartin Kaplan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Frank Barnaby’s article “The Pugwash Conference Turns 30” (THE SCIENTIST, June 29, 1987, p. 11)is, on the whole, a fair assessment of the early accomplishments of Pugwash; but it does not do justice to its activities and development during the past decade. For example, Barnaby states that Pugwash “has already begun to fade away, leaving its goal of complete nuclear disarmament still totally unfulfilled.” That goal remains the centerpiece of Pugwash’s hope for overall disarmament and the prevention of armed conflicts—one that is shared by many other organizations and all peace-loving people.

But far from “fading away,” Pugwash has in fact accelerated its pace over the past seven or eight years. During this period our annual conferences have drawn between 90 and 225 participants each, and we have held four to six symposia or workshops each year, averaging 30 participants each. (Since Pugwash started in 1957 the total attendance at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies